Baxter International Inc. (LON:0QK8)
London · Delayed Price · Currency is GBP · Price in USD 24.15
-0.20 (-0.82%)
At close: Aug 15, 2025
Baxter International Market Cap
Baxter International has a market cap or net worth of 9.26 billion as of August 21, 2025. Its market cap has decreased by -33.07% in one year.
Market Cap
9.26B
Enterprise Value
15.20B
Revenue
7.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
24.15
Market Cap Chart
Since January 2, 1968, Baxter International's market cap has increased from 611.84M to 9.26B, an increase of 1,412.77%. That is a compound annual growth rate of 4.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 9.26B | -22.17% |
| Dec 31, 2024 | 11.89B | -22.76% |
| Dec 29, 2023 | 15.40B | -27.80% |
| Dec 30, 2022 | 21.33B | -32.81% |
| Dec 31, 2021 | 31.74B | 5.75% |
| Dec 31, 2020 | 30.02B | -6.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.71B |
| GSK plc | 59.74B |
| Haleon | 33.11B |
| Smith & Nephew | 12.13B |
| ConvaTec Group | 4.99B |
| Hikma Pharmaceuticals | 4.01B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 2.03B |